Predicate |
Object |
contentType |
Clinical Trial|Comparative Study|Journal Article|Randomized Controlled Trial |
endingPage |
8B |
issn |
0300-0605 |
pageRange |
3B-8B |
publicationName |
The Journal of international medical research |
startingPage |
3B |
bibliographicCitation |
Marks P, Manna VK, Gibson JR. Acrivastine--an evaluation of initial and peak activity in human skin. J Int Med Res. 1989;17 Suppl 2():3B–8B. PMID: 2569999. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dded90d2a641f3d6c3826133c33f6097 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3bdc6a8a9169cbd3f6468b05ec6c2561 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3fc97a286ae922871e2bc1ac7345c7b7 |
date |
1989 |
identifier |
https://pubmed.ncbi.nlm.nih.gov/2569999 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3376 https://portal.issn.org/resource/ISSN/0300-0605 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ |
title |
Acrivastine--an evaluation of initial and peak activity in human skin |
discusses |
http://id.nlm.nih.gov/mesh/M0010390 http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0022015 http://id.nlm.nih.gov/mesh/M0128312 http://id.nlm.nih.gov/mesh/M0010395 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D011725Q000627 http://id.nlm.nih.gov/mesh/D014311Q000627 http://id.nlm.nih.gov/mesh/D006634Q000627 http://id.nlm.nih.gov/mesh/D014581Q000188 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D014311Q000031 http://id.nlm.nih.gov/mesh/D006632 http://id.nlm.nih.gov/mesh/D014581Q000139 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D011897 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D002986 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284514 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8096 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID774 |